Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children

Journal of Asthma

Volumn 50, Issue 8, 2013, Pages 803-809

  Hamzaoui, Agnes ^a,b,c   Berraies, Anissa ^a,b,c   Kaabachi, Wajih ^b,c   Haifa, Maalmi ^b,c   Ammar, Jamel ^a,b,c   Kamel, Hamzaoui ^b,c  

^a ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^b Unit Research Homeostasis and Cell Dysfunction   (Tunisia)

^c UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Immunopathogenesis; Pediatrics; Phenotypes

Indexed keywords

CYTOKINE; INTERLEUKIN 33; MESSENGER RNA; ST2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRESCHOOL CHILD; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SPUTUM ANALYSIS; SPUTUM LEVEL;

EID: 84884216926     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2013.816317     Document Type: Article

References (39)

1. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304
2. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green HR, Bradding P, et al. Evidence of a role of tumor necrosis factor a in refractory asthma. N Engl J Med 2006;354:697-708
3. Brightling C, Berry M, Amrani Y. Targeting TNF-A: A novel therapeutic approach for asthma. J Allergy Clin Immunol 2008; 121:5-10
4. Barnes PJ. New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 2007;119:1055-1062
5. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-Associated cytokines. Immunity 2005;23: 479-490
6. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-Associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007;104:282-287
7. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, Nambu A, et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 2010;107: 18581-18586
8. Lloyd CM. IL-33 family members and asthma-bridging innate and adaptive immune responses. Curr Opin Immunol 2010;22: 800-806
9. Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Kuchler AM. Interleukin-33 cytokine of dual function or novel alarmiñ Trends Immunol 2009;30:227-233
10. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, von Mutius E, et al. A large-scale, consortium-based genome wide association study of asthma. N Engl J Med 2010;363: 1211-1221
11. Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, Thorleifsson G. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009;41:342-347
12. Wjst M, Sargurupremraj M, Arnold M. Genome-wide association studies in asthma: What they really told us about pathogenesis. Curr Opin Allergy Clin Immunol 2013;13:112-118
13. Borish L, Steinke JW. Interleukin-33 in asthma: How big of a role does it play? Curr Allergy Asthma Rep 2011;11:7-11
14. Xu D, Chan WL, Leung BP, Huang FP, Wheeler R, Piedrafita D, Robinson JH, Liew FY. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998; 187:787-794
15. Koyasu S, Moro K. Innate Th2-Type immune responses and the natural helper cell, a newly identified lymphocyte population. Curr Opin Allergy Clin Immunol 2011;11:109-114
16. Grotenboer NS, Ketelaar ME, Koppelman GH, Nawijn MC. Decoding asthma: Translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J Allergy Clin Immunol 2013;131:856-865
17. Bianchetti L, Marini MA, Isgrò M, Bellini A, Schmidt M, Mattoli S. IL-33 promotes the migration and proliferation of circulating fibrocytes from patients with allergen-exacerbated asthma. Biochem Biophys Res Commun 2012;426:116-121
18. Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemière C, et al. Increased expression of IL-33 in severe asthma: Evidence of expression by airway smooth muscle cells. J Immunol 2009;183: 5094-5103
19. Préfontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, Hamid Q. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010; 125:752-754
20. Iwahana H, Yanagisawa K, Ito-Kosaka A, Kuroiwa K, Tago K, Komatsu N, Katashima R, et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptorrelated human ST2 gene in UT-7 and TM12 cells. Eur J Biochem 1999;264:397-406
21. Brunner M, Krenn C, Roth G, Moser B, Dworschak M, Jensen-Jarolim E, Spittler A, et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intens Care Med 2004;30:1468-1473
22. Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, Solomon SD, Rouleau JL, Lee RT. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002;106: 2961-2966
23. Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, Tominaga SI, Sugiyama Y. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001;164:277-281
24. Nabe T. Tumor necrosis factor alpha-mediated asthma? Int Arch Allergy Immunol 2013;160:111-113
25. Van Weel C, Bateman ED, Bousquet J, Reid J, Grouse L, Schermer T, Valovirta E, Zhong N. Asthma management pocket reference 2008. Allergy 2008;63:997-1004
26. Hamzaoui A, Maalmi H, Berraïes A, Abid H, Ammar J, Hamzaoui K. Transcriptional characteristics of CD4 T cells in young asthmatic children: RORC and FOXP3 axis. J Inflamm Res 2011;4:139-146
27. Hamzaoui A, Ammar J, Hamzaoui K. Regulatory T cells in induced sputum of asthmatic children: Association with inflammatory cytokines. Multidiscip Respir Med 2010;5:22-30
28. Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili Boussen I, Haj Sassi F. Serum IL-33 levels and skin mRNA expression in Behçet's disease. Clin Exp Rheumatol 2013. PubMed PMID: 23464866
29. Chu DK, Llop-Guevara A, Walker TD, Flader K, Goncharova S, Boudreau JE, Moore CL, et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol 2013;131:187-200
30. Hardman CS, Panova V, McKenzie AN. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol 2013;43: 488-498
31. Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE. IL-33 amplifies both Th1-And Th2-Type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 2008;20:1019-1030
32. Ali M, Zhang G, Thomas WR, McLean CJ, Bizzintino JA, Laing IA, Martin AC, et al. Investigations into the role of ST2 in acute asthma in children. Tissue Antigens 2009;73:206-212
33. Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007;282:26369-26380
34. Yin H, Li XY, Liu T, Yuan BH, Zhang BB, Hu SL, Gu HB, et al. Adenovirus-mediated delivery of soluble ST2 attenuates ovalbumininduced allergic asthma in mice. Clin Exp Immunol 2012;170:1-9
35. Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008;121:1484-1490
36. Moulin D, Donzé O, Talabot-Ayer D, Mézin F, Palmer G, Gabay C. Interleukin (IL)-33 induces the release of proinflammatory mediators by mast cells. Cytokine 2007;40: 216-225
37. Chiang CH, Chuang CH, Liu SL, Shen HD. Genetic polymorphism of transforming growth factor-b1 and tumor necrosis factor-A is associated with asthma and modulate the severity of asthma. Respir Care 2013 [Epub ahead of print
38. Lugogo NL, Hollingsworth JW, Howell DL, Que LG, Francisco D, Church TD, Potts-Kant EN, et al. Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype. Am J Respir Crit Care Med 2012;186:404-411
39. Kim YH, Park CS, Lim DH, Ahn SH, Son BK, Kim JH, Jang TY. Beneficial effect of anti-interleukin-33 on the murine model of allergic inflammation of the lower airway. J Asthma 2012;49: 738-743